Skip to main content
ZheJiang Tailin Bioengineering Co.,Ltd logo

ZheJiang Tailin Bioengineering Co.,Ltd — Investor Relations & Filings

Ticker · 300813 ISIN · CNE100003S89 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,000 across all filing types
Latest filing 2023-03-27 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300813

About ZheJiang Tailin Bioengineering Co.,Ltd

https://www.tailingood.com

ZheJiang Tailin Bioengineering Co.,Ltd. specializes in the research, development, and manufacturing of high-tech equipment for life sciences and pharmaceutical engineering. The company provides integrated solutions for microbial control, sterility testing, and aseptic processing. Its core product portfolio includes sterility test canisters and pumps, microbial limit testing systems, and hydrogen peroxide vapor (VHP) decontamination units. Tailin also develops advanced isolator technology for containment and aseptic applications, alongside analytical instruments such as Total Organic Carbon (TOC) analyzers and filter integrity testers. These products are designed to meet international regulatory standards, including GMP, USP, and EP. The company serves sectors such as biopharmaceuticals, medical devices, and laboratory research, focusing on product safety and quality through specialized engineering and microbial detection technologies.

Recent filings

Filing Released Lang Actions
关于独立董事辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of an independent director from the company's board. It details the director's resignation, the impact on the board composition, and the company's plan to fill the vacancy. There is no financial data, no mention of financial results, no report attached or referenced, and no regulatory certification. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2023-03-27 Chinese
关于全资子公司变更注册地址并完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the change of registered addresses of its wholly-owned subsidiaries and completion of related business registration changes. It contains no financial data, no discussion of financial results, no voting results, no management or board changes, no legal proceedings, no capital or financing updates, and no mention of any report publication. The document is a regulatory announcement about corporate administrative changes, specifically address changes of subsidiaries, which fits best under general regulatory announcements that do not fit other categories.
2023-03-24 Chinese
第三届董事会第十二次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of a board meeting resolution by Zhejiang Tailin Biotechnology Co., Ltd. It details the convening of the third board's twelfth meeting, the agenda discussed, and the voting results on a specific matter related to convertible bond conversion price adjustment. The document does not contain financial statements or detailed financial data but rather reports on board decisions and meeting procedures. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the company's board of directors or senior management.
2023-03-17 Chinese
关于不向下修正泰林转债转股价格的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from Zhejiang Tailin Biotechnology Co., Ltd. regarding the decision not to downward adjust the conversion price of its convertible bonds (referred to as 'Tailin Convertible Bonds'). It details the bond issuance, the triggering event for the price adjustment clause, the board meeting decision, and the rationale behind not adjusting the conversion price. The document is regulatory in nature, providing an update on convertible bond terms and board resolutions, but it does not contain financial statements, earnings data, or detailed financial analysis. It is not a full financial report, earnings release, or management discussion. It is also not a proxy statement or voting result announcement. Given the content and length (2368 characters), it fits best as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements and compliance disclosures that do not fit other categories.
2023-03-17 Chinese
关于预计触发泰林转债转股价格修正条件的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Zhejiang Tailin Biotechnology Co., Ltd. regarding the expected triggering of a downward adjustment condition for the conversion price of its convertible bonds (referred to as 'Tailin Convertible Bonds'). It details the bond issuance, listing, conversion period, and the adjustment mechanism for the conversion price, including regulatory references to the China Securities Regulatory Commission and Shenzhen Stock Exchange rules. The document is a formal disclosure about a potential price adjustment event and the related procedural steps, aimed at informing investors about the risk and upcoming corporate actions. It does not contain financial statements or comprehensive financial data, nor is it a full report like an annual or interim report. It is a regulatory announcement about a capital/financing matter (convertible bond price adjustment). Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is 2554 characters, which is consistent with an announcement rather than a full report.
2023-03-10 Chinese
长城证券股份有限公司关于浙江泰林生物技术股份有限公司持续督导之2022年度培训情况报告
Regulatory Filings Classification · 95% confidence The document is a report from a sponsoring securities company about a 2022 annual training session conducted for a company under continuous supervision related to convertible bond issuance. It details the training content, participants, and outcomes. The document is short (1002 characters) and focuses on a specific training event rather than financial results, governance changes, or regulatory filings. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is not an announcement of voting results, capital changes, or legal proceedings. The document is a formal report on a compliance training activity related to regulatory supervision. This type of document does not match any of the more common financial or governance filings but is best classified under Regulatory Filings (RNS) as a miscellaneous regulatory compliance report.
2023-02-28 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.